688613.SS

Allgens Medical Technology Co. Ltd. 688613.SS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 688613.SS 300326.SZ 300289.SZ 002022.SZ 300642.SZ 300318.SZ 300314.SZ 603387.SS 300562.SZ 688338.SS
6M 47.24 % 2.06 % 69.98 % 22.26 % 102.96 % -15.93 % 17.11 % 2.14 % 3.71 % 12.07 %
YTD 34.94 % -7.03 % 59.42 % 8.57 % 92.58 % 2.52 % 29.00 % 1.00 % 1.38 % 13.88 %
1Y 45.62 % 15.76 % 56.50 % 6.12 % 80.13 % -3.23 % 12.71 % -1.82 % -0.92 % 8.04 %
3Y -16.67 % -25.63 % 22.61 % -50.89 % 18.10 % -13.51 % -2.83 % -40.19 % 44.67 % 4.09 %
5Y -75.00 % -72.14 % -4.23 % -66.93 % -18.94 % -72.28 % -31.05 % -60.80 % -41.24 % -56.56 %
10Y -75.00 % -51.04 % -53.61 % -72.22 % 38.96 % -44.15 % -62.45 % -2.76 % 99.00 % -79.57 %
From the beginning -75.00 % 35.84 % 16.67 % 298.85 % 38.96 % 94.20 % 69.68 % -2.76 % 99.00 % -79.57 %

Dividend

Allgens Medical Technology Co. Ltd.

Shanghai Kinetic Medical Co., Ltd

Beijing Leadman Biochemistry Co.,Ltd.

Shanghai Kehua Bio-Engineering Co.,Ltd

Tellgen Corporation

Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Ningbo David Medical Device Co., Ltd.

Getein Biotech, Inc

Guangdong Transtek Medical Electronics Co., Ltd

Beijing Succeeder Technology Inc.